Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02084212
Other study ID # ISAICO-MUSELIER AOI 2011
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date March 6, 2013
Est. completion date April 24, 2015

Study information

Verified date September 2019
Source Centre Hospitalier Universitaire Dijon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this research is to assess current care by studying macular function using microperimetry and by then comparing visual acuity results with OCT (Optical Coherence Tomography) data.

The examinations performed are those usually done in the follow-up of epiretinal membrane surgery, apart from microperimetry which is an examination of the central visual field. Patients who undergo ERM surgery usually have a follow-up examination at 1 month, 3 months and 6 months after the surgery. The consultation includes an assessment of visual acuity, a fundus examination an SD-OCT of the retina. The present protocol will require no additional visits. The microperimetry will be done in addition to the usual follow-up examinations after ERM surgery.


Recruitment information / eligibility

Status Terminated
Enrollment 6
Est. completion date April 24, 2015
Est. primary completion date April 24, 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Persons who have provided consent,

- Patients about to undergo idiopathic epiretinal membrane surgery,

- Patients undergoing first-line macular surgery

Exclusion Criteria:

- Persons not covered by national health insurance

- Preexisting disease of macula/epiretinal membrane (ARMD, chorioretinal scarring)

- Preoperative amblyopic eye

- Insufficiently transparent media making it impossible to do the examinations

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Microperimetry


Locations

Country Name City State
France CHU de DIJON Dijon

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire Dijon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of visual acuity in ETDRS (Early Treatment Diabetic Retinopathy Study) scale Up to 6 months after the operation.
Primary Anomalies observed in the outer layers of retina Up to 6 months after the operation
Primary Evaluation of retinal sensitivity by microperimetry Up to 6 months after the operation
Secondary Abnormal surface autofluorescence Up to 6 months after the operation